
Aliada Therapeutics
Aliada Therapeutics: Innovating CNS disease treatment through novel biotech solutions.
- 14
- Series C
Aliada Therapeutics is a biotechnology company focused on developing novel therapies to treat central nervous system (CNS) diseases. Utilizing its proprietary Modular Delivery (MODEL) platform, Aliada designs small modular protein domains optimized for efficient blood-brain barrier (BBB) transport and therapeutic functionality. The company aims to advance CNS target antibody binders through preclinical evaluation, providing innovative solutions for medical professionals treating CNS disorders.
Aliada Therapeutics has made significant strides in the biotech industry by leveraging the MODEL platform, originally designed by Janssen researchers. This platform's ability to efficiently transport therapeutic modules across the BBB has positioned Aliada as a key player in CNS disease treatment innovation. The company's work has garnered attention for its potential to revolutionize how CNS diseases are managed, impacting both the scientific community and patient care.
Similar Companies

MapLight Therapeutics
maplightrx.com
Adenios

Allyx Therapeutics
allyxthera.com

Kurve Therapeutics
kurvetx.com

MindImmune Therapeutics
mindimmune.com

Bolden Therapeutics

Alltrna
alltrna.com

Ilios
iliostx.com

Atalanta Therapeutics
atalantatx.com

Arialys Therapeutics
arialysrx.com

Bonum Therapeutics
bonumtx.com

Ampersand Biomedicines
ampersand.bio

Affinia Therapeutics
affiniatx.com

Halia Therapeutics
haliatx.com

Libra Therapeutics
Quick Facts
Who are Aliada Therapeutics' competitors?
Companies similar to Aliada Therapeutics include MapLight Therapeutics, Adenios, Allyx Therapeutics and Kurve Therapeutics.
When was Aliada Therapeutics founded?
Aliada Therapeutics was founded in 2021.
Where is Aliada Therapeutics' headquarters located?
Aliada Therapeutics' headquarters is located in Boston, MA, US.
When was Aliada Therapeutics' last funding round?
Aliada Therapeutics' most recent funding round was for $32M (USD) in December 2022.
How much disclosed funding has Aliada Therapeutics raised?
As of Dec 30, 2022, Aliada Therapeutics has disclosed funding of $32M (USD). Undisclosed round amounts are excluded.
How many employees does Aliada Therapeutics have?
Aliada Therapeutics has 14 employees as of Feb 5, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Model
- Customer
- Main Product
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
Show 13 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified